Cargando…
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
Diabetes compromises bone cell metabolism and function, resulting in increased risk of fragility fracture. Advanced glycation end products (AGEs) interact with the receptor for AGEs (RAGE) and can make a meaningful contribution to bone cell metabolism and/or alter function. Searches in PubMed using...
Autores principales: | Asadipooya, Kamyar, Uy, Edilfavia Mae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734192/ https://www.ncbi.nlm.nih.gov/pubmed/31528827 http://dx.doi.org/10.1210/js.2019-00160 |
Ejemplares similares
-
Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole
por: Raj, Rishi, et al.
Publicado: (2019) -
Advanced glycation end products regulate the receptor of AGEs epigenetically
por: Wu, Xiaoqing, et al.
Publicado: (2023) -
Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs
por: Lee, Eun Jung, et al.
Publicado: (2016) -
Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010) -
Advanced Glycation End Products, Diabetes, and Bone Strength
por: Yamamoto, Masahiro, et al.
Publicado: (2016)